KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has disclosed Change in Inventory for 4 consecutive years, with -$694000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Change in Inventory fell 16.64% year-over-year to -$694000.0, compared with a TTM value of -$7.5 million through Jun 2023, down 238.38%, and an annual FY2022 reading of -$164000.0, down 126.2% over the prior year.
  • Change in Inventory was -$694000.0 for Q2 2023 at Ginkgo Bioworks Holdings, up from -$1.9 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $5.3 million in Q1 2022 and bottomed at -$2.7 million in Q4 2022.
  • Average Change in Inventory over 4 years is -$15454.5, with a median of -$595000.0 recorded in 2022.
  • Peak annual rise in Change in Inventory hit 683.41% in 2022, while the deepest fall reached 2276.79% in 2022.
  • Year by year, Change in Inventory stood at $1.9 million in 2020, then tumbled by 105.84% to -$112000.0 in 2021, then crashed by 2276.79% to -$2.7 million in 2022, then soared by 73.93% to -$694000.0 in 2023.
  • Business Quant data shows Change in Inventory for DNA at -$694000.0 in Q2 2023, -$1.9 million in Q1 2023, and -$2.7 million in Q4 2022.